HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lian, J. P. Articles by Badwey, J. A. Search for Related Content PubMed PubMed Citation Articles by Lian, J. P. Articles by Badwey, J. A.

Antagonists of Calcium Fluxes and Calmodulin Block Activation of the p21-Activated Protein Kinases in Neutrophils¹

Jian P. Lian^*, Lisa Crossley^*, Qian Zhan^*, Riyun Huang, Paul Coffer, Alex Toker, Dwight Robinson^§ and John A. Badwey^2,*,¶

^* Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, MA 02115; Boston Biomedical Research Institute, Boston, MA 02114; Department of Pulmonary Diseases, University Hospital Utrecht, Utrecht, The Netherlands; ^§ Arthritis Unit, Massachusetts General Hospital, Boston, MA 02114; and ^¶ Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

Neutrophils stimulated with fMLP or a variety of other chemoattractants that bind to serpentine receptors coupled to heterotrimeric G proteins exhibit rapid activation of two p21-activated protein kinases (Paks) with molecular masses of 63 and 69 kDa (- and -Pak). Previous studies have shown that products of phosphatidylinositol 3-kinase and tyrosine kinases are required for the activation of Paks. We now report that a variety of structurally distinct compounds which interrupt different stages in calcium/calmodulin (CaM) signaling block activation of the 63- and 69-kDa Paks in fMLP-stimulated neutrophils. These antagonists included selective inhibitors of phospholipase C (1-[6-((17-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-dione), the intracellular Ca²⁺ channel (8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate), CaM (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide; N-(4-aminobutyl)-5-chloro-1-naphthalenesulfonamide; trifluoperazine), and CaM-activated protein kinases (N-[2-(N-(chlorocinnamyl)-N-methylaminomethyl)phenyl]-N-[2-hydroxyethyl]-4-methoxybenzenesulfonamide). This inhibition was dose-dependent with IC₅₀ values very similar to those that interrupt CaM-dependent reactions in vitro. In contrast, less active analogues of these compounds (1-[6-((17-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-2,5-pyrrolidinedione; N-(6-aminohexyl)-1-naphthalenesulfonamide; N-(4-aminobutyl)-1-naphthalenesulfonamide; promethazine; 2-[N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzyl-amine]) did not affect activation of Paks in these cells. CaM antagonists (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide; trifluoperazine), but not their less-active analogues (N-(6-aminohexyl)-1-naphthalenesulfonamide; promethazine), were also found to block activation of the small GTPases Ras and Rac in stimulated neutrophils along with the extracellular signal-regulated kinases. These data strongly suggest that the Ca²⁺/CaM complex plays a major role in the activation of a number of enzyme systems in neutrophils that are regulated by small GTPases.

This article has been cited by other articles:

				Y.-P. Ching, V. Y.L. Leong, M.-F. Lee, H.-T. Xu, D.-Y. Jin, and I. O.-L. Ng P21-Activated Protein Kinase Is Overexpressed in Hepatocellular Carcinoma and Enhances Cancer Metastasis Involving c-Jun NH2-Terminal Kinase Activation and Paxillin Phosphorylation Cancer Res., April 15, 2007; 67(8): 3601 - 3608. [Abstract] [Full Text] [PDF]

				E. A. Woolfolk, S. Eguchi, H. Ohtsu, H. Nakashima, H. Ueno, W. T. Gerthoffer, and E. D. Motley Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1286 - C1294. [Abstract] [Full Text] [PDF]

				U. K. Misra, T. Sharma, and S. V. Pizzo Ligation of Cell Surface-Associated Glucose-Regulated Protein 78 by Receptor-Recognized Forms of {alpha}2-Macroglobulin: Activation of p21-Activated Protein Kinase-2-Dependent Signaling in Murine Peritoneal Macrophages J. Immunol., August 15, 2005; 175(4): 2525 - 2533. [Abstract] [Full Text] [PDF]

				S. Verploegen, L. Ulfman, H. W. M. van Deutekom, C. van Aalst, H. Honing, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function Blood, August 1, 2005; 106(3): 1076 - 1083. [Abstract] [Full Text] [PDF]

				Z. Yang, R. K. Vadlamudi, and R. Kumar Dynein Light Chain 1 Phosphorylation Controls Macropinocytosis J. Biol. Chem., January 7, 2005; 280(1): 654 - 659. [Abstract] [Full Text] [PDF]

				P. C. Chu, J. Wu, X. C. Liao, J. Pardo, H. Zhao, C. Li, M. K. Mendenhall, E. Pali, M. Shen, S. Yu, et al. A Novel Role for p21-Activated Protein Kinase 2 in T Cell Activation J. Immunol., June 15, 2004; 172(12): 7324 - 7334. [Abstract] [Full Text] [PDF]

				P. D. Arora, M. Glogauer, A. Kapus, D. J. Kwiatkowski, and C. A. McCulloch Gelsolin Mediates Collagen Phagocytosis through a Rac-dependent Step Mol. Biol. Cell, February 1, 2004; 15(2): 588 - 599. [Abstract] [Full Text] [PDF]

				Q. Zhan, Q. Ge, T. Ohira, T. Van Dyke, and J. A. Badwey p21-Activated Kinase 2 in Neutrophils Can Be Regulated by Phosphorylation at Multiple Sites and by a Variety of Protein Phosphatases J. Immunol., October 1, 2003; 171(7): 3785 - 3793. [Abstract] [Full Text] [PDF]

				A. R. Burns, C. W. Smith, and D. C. Walker Unique Structural Features That Influence Neutrophil Emigration Into the Lung Physiol Rev, April 1, 2003; 83(2): 309 - 336. [Abstract] [Full Text] [PDF]